advertisement

alternative health

what canada’s special access program means for patients and doctors

and why advocates say the program doesn't go far enough.
sam riches
jan 17 2022

four things cbd won’t help a user achieve in 2022

while cbd might help treat symptoms of a condition, it’s not medicine and it likely won’t resolve a medical condition all on its own.
maria loreto - the fresh toast
jan 11 2022

exclusive: three canadians with mental health conditions receive legal access to psilocybin mushrooms

exemptions show a shift in approval criteria but "the process is still broken," advocates say
sam riches
dec 14 2021

use of psychedelics climbs globally while consumption of most other drugs drops

findings from global drug survey suggest covid-19 may have played a role in lower cannabis use.
angela stelmakowich
dec 2 2021

new graphic novel explores psychedelic research on the prairies

erika dyck's research delves into the history of medical lsd trials in saskatchewan in the 1950s.
the star phoenix
nov 25 2021

thc and inflammation: what does the relationship between the two mean for health?

beyond its reported effectiveness, a main perk is that weed is generally not associated with significant side effects.
the growthop
nov 16 2021

therapsil launches psilocybin-therapy study alongside university researchers

the study aims to understand the impact of psilocybin-assisted psychotherapy on canadian patients who experience end-of-life distress.
sam riches
nov 10 2021

company launches cannabis suppository products for both medical and adult use

cross-country offering will include two distinct products, one with thc and the other with cbd.
angela stelmakowich, the growth op
nov 10 2021
powered by
canadian digestive health foundation
powered by
the leukemia & lymphoma society of canada (llsc)

what canada’s special access program means for patients and doctors

and why advocates say the program doesn't go far enough.
sam riches
jan 17 2022

four things cbd won’t help a user achieve in 2022

while cbd might help treat symptoms of a condition, it’s not medicine and it likely won’t resolve a medical condition all on its own.
maria loreto - the fresh toast
jan 11 2022

exclusive: three canadians with mental health conditions receive legal access to psilocybin mushrooms

exemptions show a shift in approval criteria but "the process is still broken," advocates say
sam riches
dec 14 2021

use of psychedelics climbs globally while consumption of most other drugs drops

findings from global drug survey suggest covid-19 may have played a role in lower cannabis use.
angela stelmakowich
dec 2 2021
powered by
canadian digestive health foundation

new graphic novel explores psychedelic research on the prairies

erika dyck's research delves into the history of medical lsd trials in saskatchewan in the 1950s.
the star phoenix
nov 25 2021

thc and inflammation: what does the relationship between the two mean for health?

beyond its reported effectiveness, a main perk is that weed is generally not associated with significant side effects.
the growthop
nov 16 2021

therapsil launches psilocybin-therapy study alongside university researchers

the study aims to understand the impact of psilocybin-assisted psychotherapy on canadian patients who experience end-of-life distress.
sam riches
nov 10 2021

company launches cannabis suppository products for both medical and adult use

cross-country offering will include two distinct products, one with thc and the other with cbd.
angela stelmakowich, the growth op
nov 10 2021
powered by
the leukemia & lymphoma society of canada (llsc)

advertisement

advertisement